Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Comparison of Muscle Atrophy Signaling Effects

MuRF1 mRNA Elevated Reduced in some models Moderate MAFbx mRNA Trend toward reduction Limited FOXO3a nuclear localization Increased Reduced (AMPK-dependent) SMAD2/3 phosphorylation Modest reduction in some studies Limited/preliminary Myostatin protein levels E

This comparison does not assign a generated winner or score.

  • MuRF1 mRNA
  • Elevated
  • Reduced in some models
  • Moderate
  • MAFbx mRNA
  • Trend toward reduction
  • Limited
  • FOXO3a nuclear localization
  • Increased
  • Reduced (AMPK-dependent)
  • SMAD2/3 phosphorylation
  • Modest reduction in some studies
  • Limited/preliminary
  • Myostatin protein levels
  • Elevated in atrophy
  • Mixed findings
  • Inconsistent
  • Myotube diameter
  • Reduced (atrophy)
  • Partially preserved
  • mTORC1 activity
  • Variable
  • May be reduced (AMPK effect)
  • Context-dependent
More references

Related material

Comparison

AICAR Pathway Comparison

Some researchers have compared MOTS-c's metabolic effects to those of AICAR (5-aminoimidazole-4-carboxamide ribonucleotide), a well-characterized pharmacological AMPK activator. B…

View details →
Comparison

MOTS-C Concentration Comparison

0.5mg/mL 10mL bacteriostatic water 0.4mL 25 doses High-precision titration studies; small incremental dosing Maximises dose count but requires large injection volumes; impractical…

View details →